Dendritic Cells Conditioned With NK026680 Prolong Cardiac Allograft Survival in Mice

Background Pharmacologically modulated dendritic cells (DCs) can potentially regulate alloimmune responses. We examined the characteristics of immunoregulatory DCs induced by a novel triazolopyrimidine derivative, NK026680, which has been previously shown to inhibit DC maturation. Methods DCs were generated from bone marrow progenitor cells from C57BL/6 (B6, H-2b haplotype) mice with granulocyte-macrophage colony-stimulating factor and interleukin (IL)-4. DCs were cultured with allogeneic BALB/c (H-2d) splenocyte lysates with or without NK026680. DC functions were examined in vitro after stimulation of tumor necrosis factor &agr; and in vivo by the intravenous injection of C3He/J (C3H, H-2k) DCs cultured with B6 cell lysates and NK026680 into C3H mice. Seven days later, DC-treated mice received B6 heart allografts, and graft survival and alloimmune responses were assessed. Results In NK026680-treated DCs (NK-DCs), significant inhibition of the up-regulation of surface activation markers (CD40, CD80, CD86, and major histocompatibility complex class II) and IL-12 p40 production was observed after stimulation of tumor necrosis factor &agr; compared with that of control DCs. Furthermore, NK-DCs suppressed alloreactive T-cell proliferation. The modulation of NK-DCs was likely associated with the inhibition of phosphorylation of p38 mitogen-activated protein kinase and the up-regulation of indolamine 2,3-dioxygenase expression. Compared with both noninjected and control DC–injected mice, mice that received a single in vivo infusion of NK-DCs showed significant increases in splenocyte IL-10 production and the splenic CD4+ IL-10high T-cell population 7 days after injection, a significantly increased splenic CD4+CD25+FoxP3+ T-cell population 14 days after injection, and markedly prolonged cardiac allograft survival. Conclusions Ex vivo NK026680 conditioning allows DCs to acquire immunoregulatory properties that suppress alloimmune responses and prolong cardiac allograft survival.

[1]  D. Munn,et al.  The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation1 , 2008, The Journal of Immunology.

[2]  Motohiko Suzuki,et al.  Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. , 2008, Clinical immunology.

[3]  Motohiko Suzuki,et al.  Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance. , 2008, International immunology.

[4]  B. Baban,et al.  Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. , 2007, The Journal of clinical investigation.

[5]  Yoshinobu Sato,et al.  A Novel Chemical Compound, NK026680, Targets Dendritic Cells to Prolong Recipient Survival After Rat Liver Grafting , 2007, Transplantation.

[6]  A. Thomson,et al.  Tolerogenic dendritic cells and the quest for transplant tolerance , 2007, Nature Reviews Immunology.

[7]  Zhiliang Wang,et al.  Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance1 , 2007, The Journal of Immunology.

[8]  S. Todo,et al.  Control of Allograft Rejection by Applying a Novel Nuclear Factor-&kgr;B Inhibitor, Dehydroxymethylepoxyquinomicin , 2006, Transplantation.

[9]  M. Ono,et al.  NK026680, a novel suppressant of dendritic cell function, prevents the development of rapidly progressive glomerulonephritis and perinuclear antineutrophil cytoplasmic antibody in SCG/Kj mice. , 2006, Arthritis and rheumatism.

[10]  M. Ono,et al.  NK026680, a novel compound suppressive of dendritic cell function, ameliorates mortality in acute lethal graft-versus-host reaction in mice , 2006, Bone Marrow Transplantation.

[11]  J. Fung,et al.  Prolongation of Cardiac Allograft Survival by Systemic Administration of Immature Recipient Dendritic Cells Deficient in NF-κB Activity , 2005, Annals of surgery.

[12]  Zhiliang Wang,et al.  Rapamycin‐Treated, Alloantigen‐Pulsed Host Dendritic Cells Induce Ag‐Specific T Cell Regulation and Prolong Graft Survival , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  D. Munn,et al.  Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[14]  S. Nakagawa,et al.  p38 Mitogen-Activated protein kinase mediates dual role of ultraviolet B radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells. , 2004, The Journal of investigative dermatology.

[15]  M. Ostrowski,et al.  The Role of the p38 Mitogen-Activated Protein Kinase, Extracellular Signal-Regulated Kinase, and Phosphoinositide-3-OH Kinase Signal Transduction Pathways in CD40 Ligand-Induced Dendritic Cell Activation and Expansion of Virus-Specific CD8+ T Cell Memory Responses 1 , 2004, The Journal of Immunology.

[16]  T. Ichim,et al.  LF15‐0195 generates tolerogenic dendritic cells by suppression of NF‐κB signaling through inhibition of IKK activity , 2003, Journal of leukocyte biology.

[17]  T. Ichim,et al.  Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells. , 2003, Transplant immunology.

[18]  R. Lechler,et al.  Regulatory T Cells in the Control of Transplantation Tolerance and Autoimmunity , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  S. Nakagawa,et al.  p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. , 2003, The Journal of investigative dermatology.

[20]  H. Waldmann,et al.  Regulating the immune response to transplants. a role for CD4+ regulatory cells? , 2001, Immunity.

[21]  V. Kindler,et al.  A Critical Role for p38 Mitogen-Activated Protein Kinase in the Maturation of Human Blood-Derived Dendritic Cells Induced by Lipopolysaccharide, TNF-α, and Contact Sensitizers , 2001, The Journal of Immunology.

[22]  M. Yacoub,et al.  Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. , 2000, Circulation.

[23]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[24]  D. Hart,et al.  Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.

[25]  T. Starzl,et al.  Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. , 1995, Transplantation.

[26]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[27]  R. Schwartz,et al.  Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. , 1990, Journal of immunology.

[28]  R. Corry,et al.  PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE: THE ROLE OF H‐2D, H‐2K, AND NON‐H-2 ANTIGENS IN REJECTION , 1973, Transplantation.

[29]  柴崎 晋.  NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats , 2012 .

[30]  H. Waldmann,et al.  Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.

[31]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.